Fenwick Represents Clarium in $10.5M Strategic Financing Round

Fenwick represented Clarium, a healthcare technology company specializing in hospital supply chain operations, in its $10.5 million strategic financing round. The round was led by General Catalyst, with participation from Kaiser Permanente Ventures, Texas Medical Center Venture Fund, Yale New Haven Health, and existing investors AlleyCorp, 1984 Ventures, Alumni Ventures, and others.

Clarium will use the funds to continue recruiting exceptional talent across data science, engineering, sales, product, and customer success to meet the needs of its growing customer base. Clarium will also build programs with additional health systems and build on and refine its platform’s product offerings and continue to invest in generative AI. More information can be obtained from the company’s announcement.

The Fenwick transaction team was led by corporate partner Thomas Kang and included associate Shannon Lieu.